1ESR
CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2
Summary for 1ESR
| Entry DOI | 10.2210/pdb1esr/pdb |
| Related | 1BO0 1DOK 1DOL 1DOM |
| Descriptor | MONOCYTE CHEMOTACTIC PROTEIN 2 (2 entities in total) |
| Functional Keywords | cytokine, chemokine, monocyte chemoattractant protein, hiv-1, pyroglutamic acid |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 8911.38 |
| Authors | Blaszczyk, J.,Ji, X. (deposition date: 2000-04-10, release date: 2000-12-06, Last modification date: 2024-11-20) |
| Primary citation | Blaszczyk, J.,Coillie, E.V.,Proost, P.,Damme, J.V.,Opdenakker, G.,Bujacz, G.D.,Wang, J.M.,Ji, X. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry, 39:14075-14081, 2000 Cited by PubMed Abstract: Monocyte chemotactic protein 2 (MCP-2) is a CC chemokine that utilizes multiple cellular receptors to attract and activate human leukocytes. MCP-2 is a potent inhibitor of HIV-1 by virtue of its high-affinity binding to the receptor CCR5, one of the major coreceptors for HIV-1. Although a few structures of CC chemokines have been reported, none of these was determined with the N-terminal pyroglutamic acid residue (pGlu1) and a complete C-terminus. pGlu1 is essential for the chemotactic activity of MCP-2. Recombinant MCP-2 has Gln1 at the N terminus, 12-15% of which cyclizes automatically and forms pGlu1. The chemotactic activity of such MCP-2 mixture, which contains 12-15% pGlu1-form and 85-88% Gln1-form protein, is approximately 10 times lower when compared with that of fully cyclized MCP-2 preparation. Therefore, this chemokine is practically inactive without pGlu1. We have determined the complete crystal structure of MCP-2 that contains both pGlu1 and an intact C-terminus. With the existence of pGlu1, the conformation of the N-terminus allows two additional interactions between the two subunits of MCP-2 dimer: a hydrogen bond between pGlu1 and Asn17 and a salt bridge between Asp3 and Arg18. Consequently, both pGlu1 are anchored and buried, and thereby, both N-terminal regions are protected against protease degradation. We have also observed not previously reported extended helical nature of the C terminal region, which covers residues 58-74. PubMed: 11087354DOI: 10.1021/bi0009340 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report






